Hepatitis B Foundation President Dr. Chari Cohen is quoted in a powerful new story about hepatitis B in The New Yorker. You can read it here.

News and Updates

Current News

News and Updates

12/2024: Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families

12/2024: The urgent need to end hepatitis B stigma and discrimination

12/2024: Making a major investment to fight hepatitis B in Africa

12/2024: Uptake of the hepatitis B vaccine among brothel-based female sex workers in Kampala, Uganda

12/2024: Priorities in planning person-centred hepatitis B and C testing services: operational guide

11/2024: New step in African region’s efforts to eliminate mother-to-child transmission of HIV, syphilis and hepatitis B

11/2024: Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania

11/2024: Seroprevalence of Hepatitis B virus surface antigen among African blood donors: a systematic review and meta-analysis

11/2024: Socioeconomic determinants of malaria and hepatitis infections: insights from the Federal Medical Center, Makurdi, North Central, Nigeria

11/2024: Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort study

11/2024: Health Facility Capacity and Health-care Worker Knowledge, Attitudes, and Practices of Hepatitis B Vaccine Birth-dose and Maternal Tetanus-Diphtheria Vaccine Administration in Nigeria: A Baseline Assessment

11/2024: Addressing vaccination gaps among healthcare workers in sub-Saharan Africa: the role of mandatory Hepatitis B vaccination

11/2024: Seropositivity of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative vaccinated individuals aged 5–12 years in North West Ethiopia

11/2024: Out of sight, into mind: a socioecological model-informed qualitative study on barriers and facilitators to hepatitis B care among West African immigrants in the Bronx, New York

10/2024: A prospective, multicenter study of hepatitis B birth-dose vaccine with or without hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus in Ethiopia

10/2024: GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian Patients

10/2024: Towards contextualized complex systems approaches to scaling-up hepatitis B birth-dose vaccination in the African region: A qualitative systematic review

9/2024: Availability of point-of-care HBV tests in resource-limited settings

9/2024: Epidemiology of hepatitis B virus infection among pregnant women in Africa: a systematic review and meta-analysis

9/2024: Practice on hepatitis B virus infection prevention and associated factors in Ethiopia: systematic review and meta-analysis

8/2024: The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study

8/2024: The 2024 African Viral Hepatitis Convention Declaration of Cape Town

7/2024: A new hepatitis B elimination strategy for remote populations is needed

6/2024Hepatitis B in Africa: New Tools and Progress Toward Elimination with Jodie Dionne, M.D., and Michael Vinikoor, M.D.

6/2024Gavi announces launch of preventive Ebola, routine multivalent meningitis, human rabies, and hepatitis B birth dose vaccination programmes

6/2024: Call for actions to address hepatocellular carcinoma in sub-Saharan Africa

6/2024: Screening for hepatitis B in the Bronx West African community with a blood pressure cuff: a cohort study

6/2024: African countries pledge to end ‘silent disease’

5/2024: Investigating Hepatitis B Virus-Related Hepatocellular Carcinoma Incidence

5/2024: Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia

5/2024: Assessment of Hepatitis B Virus Infection and Immunity Status Amid Inhabitants of Wukari in Taraba State, North- East Nigeria: A Community-Based Study

5/2024: Survey of lived experiences and challenges in hepatitis B management and treatment

5/2024: Clinical and Epidemiological Aspects of Hepatocellular Carcinoma at the Internal Medicine Department of Point “G” Teaching Hospital in Mali

5/2024: Deaths from Viral Hepatitis Increase Globally With Limited Access to Diagnostics and Treatment

5/2024: Hepatitis B Virus (HBV) Bridges Gap Between Policy and Implementation in Vaccine Coverage

5/2024: Liver cancer surveillance in people with hepatitis B in Africa

5/2024: Global hepatitis report 2024: action for access in low- and middle-income countries

3/2024: High risk, high reward: Gavi's investment in Africa vaccine production

3/2024: Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional study.

3/2024: Africa CDC's viral hepatitis prevention and control programme: a continental initiative to support elimination programmes

3/2024: Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional study

3/2024: Framework for an Integrated Multisectoral Response to TB, HIV, STIS and Hepatitis in the WHO African Region 2021–2030

3/2024: Introducing a framework for implementing triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus: policy brief

3/2024: Assessment of prevalence and risk factors associated with Hepatitis B virus infection among blood donors in Mogadishu Somalia

2/2024: Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional study

2/2024: Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection

2/2024: Eliminating viral hepatitis: no room for complacency

2/2024: Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study

1/2024: Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis

News Archive

10/2023: Seroprevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Blood Donors in Sidi Bel Abbes, West Algeria

10/2023: Black People Less Likely to Be Eligible for Hepatitis B Treatment

9/2023: Five-year results of a treatment program for chronic hepatitis B in Ethiopia

8/2023: A Comparison of the Awareness, Attitude, and Uptake of COVID-19, Hepatitis B Virus, and Yellow Fever Vaccines Between Rural and Urban Respondents in Edo State, Nigeria

8/2023: Somalia, WHO renew efforts to tackle viral hepatitis

8/2023: World Hepatitis Day held at Ho; over 900 screen, vaccinated

7/2023: Afenyo-Markin calls for inclusion of Hepatitis B in NHIS, assure constituents of Viral Loading Machine

7/2023: WHO Tasks Nigeria, Others On Viral Hepatitis Elimination

7/2023: Study reveals need for early diagnosis and treatment of liver disease in Africa

7/2023: World Needs to Dramatically Scale Up Hepatitis Testing and Treatment

7/2023: Ghana: Childhood Immunisation Programme - Newborns to Receive Hepatitis B Vaccines ...Within 24hrs of Birth Beginning Next Year

7/2023: Uganda elevates health for all with free hepatitis testing, treatment and vaccines

7/2023: Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus

7/2023: Recent progress in infant hepatitis B vaccination efforts in Africa

7/2023: Hepatitis B Vaccination Efforts in Africa Are Flagging

7/2023: Risk Factors for Hepatitis B Virus Infection in North Ethiopia: A Case–Control Study

7/2023: Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers

6/2023: World hepatitis day 2021 –screening and vaccination against Hepatitis B virus in Accra, Ghana.

5/2023: Modelling of Hepatitis B Virus vertical transmission dynamics in Ethiopia: a compartmental modelling approach.

4/2023: Measuring stigma associated with hepatitis B virus infection in Sierra Leone: Validation of an abridged Berger HIV stigma scale.

4/2023: Mapping hepatitis B virus genotypes on the African continent from 1997 to 2021: a systematic review with meta-analysis.

3/2023: Research uncovers cheaper diagnostic tools for chronic hepatitis B in Africa

2/2023: The development of a machine learning algorithm for early detection of viral hepatitis B infection in Nigerian patients

2/2023: Global reporting of progress towards elimination of hepatitis B and hepatitis C

1/2023: Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa.

1/2023: Simpler Tests Needed for Africa’s Chronic Hep B Patients.

12/2022: Dynamics of hepatitis B infection prevention practices among pregnant women attending antenatal care at Lubaga Hospital Kampala, Uganda using the constructs of information-motivation-behavioural skills model

9/2022: Prevalence and predictors of viral hepatitis D co-infection in chronic HbsAg carriers

8/2022: Despite global headway, Africa lags on eliminating mother-to-child HBV transmission.

7/2022: Treatment of hepatocellular carcinoma in sub-Saharan Africa: Challenges and solutions

5/2022: Low-cost scoring system informs HBV treatment eligibility in resource-limited countries.

4/2022: A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: The '2for1' project.

4/2022: Rwanda shows improvement in hepatitis treatment.

3/2022: Africa's struggles with hepatitis B.

3/2022: Breaking down barriers for hepatitis B screening in the Bronx West African community through education in collaboration with faith-based organizations: A cohort study. 

3/2022: The global fight against hepatitis B is benefitting some parts of the world more than others.

2/2022: Thirty African countries now back Africa Medicines Agency treat but continent's economic powers still hold out. 

2/2022: Implementation approaches for introducing and overcoming barriers to hepatitis B birth-dose vaccine in sub-Saharan Africa.

2/2022: Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): A single-centre, longitudinal observational study.

1/2022: Impeding the high prevalence of hepatitis B in Nigeria: The pharmacist's perspective.

1/2022: Mozambique: Maputo study on cutting mother to child transmission of hepatitis B.

1/2022: Global disparities in hepatitis B elimination - A focus on Africa.

1/2022: Viral hepatitis amidst COVID-19 in Africa: Implications and recommendations

12/2021: Burden and transmission risks of viral hepatitis in Southern Ethiopia: Evidence needed for prevention and control measures.

11/2021: Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women & their neonates in the Democratic Republic of the Congo: A feasibility study.

10/2021: Seroprevalence of hepatitis B virus and associated factors among female sex workers using respondent-driven sampling in Hawassa City, Ethiopia.

4/2021: Self-testing for HIV, HBV, and HCV using finger-stick whole-blood multiplex immunochromatographic rapid test: A pilot feasibility study in Sub-Saharan Africa

4/2021: Filtering inequality: Screening and knowledge in Senegal’s topography of hepatitis B care. 

1/2021: Prevalence of hepatitis B virus infection and factors associated with hepatitis B virus infection among pregnant women presented to antenatal care clinics at Adigrat General Hospital in Northern Ethiopia.

12/2020: A mixed-methods approach to understanding perceptions of hepatitis B and hepatocellular carcinoma among ethnically diverse Black Communities in South Florida.

7/2020: Converging pandemics: Implications of COVID-19 for the viral hepatitis response in Sub-Saharan Africa.

3/2020: Barriers to hepatitis B screening and prevention for African Immigrant Populations in the United States: A qualitative study.

1/2020: The epidemiology of hepatitis delta virus infection in Cameroon

12/2018: The silent epidemic killing more people than HIV, malaria or TB.

9/2016: A novel strategy to increase identification of African-Born People with chronic hepatitis B virus infection in the Chicago metropolitan area, 2012-2014

6/2016: A novel collaborative community-based hepatitis B screening and linkage to care program for African immigrants.

7/2014: Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection — Sub-Saharan Africa, 2000–2011

6/2014: Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: A cross-sectional study.